Life Science

Latest Research Report to uncover key Factors of Global Recombinant Therapeutic Antibodies and Proteins Market

Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein. Recombinant proteins have gained significant traction for therapeutic applications and the number of proteins either launched or approved into clinical trials has continually increased over the past two decades. According to the National Center for Biotechnology Information (NCBI) data of 2017, the U.S. Food and Drug Administration (FDA) approved over 140 recombinant therapeutic proteins for human use and several hundred are currently in development. Majority of these proteins are recombinant monoclonal antibodies.

The global recombinant therapeutic antibodies and proteins market size was valued at US$ 92.5 billion in 2017, and is expected to witness a robust CAGR of 11.2% over the forecast period (2017 – 2025).

Access Report Details at: https://www.themarketreports.com/report/global-recombinant-therapeutic-antibodies-and-proteins-market-research-report

The global Recombinant Therapeutic Antibodies and Proteins market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Recombinant Therapeutic Antibodies and Proteins volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Therapeutic Antibodies and Proteins market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in Recombinant Therapeutic Antibodies and Proteins Market report are Abbott, Amgen, Biogen, Eli Lilly, Roche, Johnson and Johnson, Merck, Novo Nordisk, Pfizer, Sanofi and more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.

Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1431731

Table of Content

1 Recombinant Therapeutic Antibodies and Proteins Market Overview

2 Global Recombinant Therapeutic Antibodies and Proteins Market Competition by Manufacturers

3 Global Recombinant Therapeutic Antibodies and Proteins Production Market Share by Regions

4 Global Recombinant Therapeutic Antibodies and Proteins Consumption by Regions

5 Global Recombinant Therapeutic Antibodies and Proteins Production, Revenue, Price Trend by Type

6 Global Recombinant Therapeutic Antibodies and Proteins Market Analysis by Applications

7 Company Profiles and Key Figures in Recombinant Therapeutic Antibodies and Proteins Business

8 Recombinant Therapeutic Antibodies and Proteins Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

11 Global Recombinant Therapeutic Antibodies and Proteins Market Forecast

12 Research Findings and Conclusion

13 Methodology and Data Source